RA May Lead to Worse Pregnancy Outcomes Compared With SpA
Compared with women with and without spondyloarthritis, women with rheumatoid arthritis have a higher risk of worse maternal and neonatal outcomes.
All articles by Rheumatology Advisor Contributing Writer
Determining the Appropriate Use of Trackable Pills and Other Nanodrugs
Although trackable and other nanotechnologies represent medical breakthroughs for treatment of many diseases, they could have unintended implications and thus their use must be carefully considered in the individual case.
Elevated Baseline CRP Associated With Greater Structural Progression in PsA
In this post-hoc analysis, elevated C-reactive protein levels at baseline were associated with greater structural progression in patients with PsA who had an inadequate response to conventional synthetic DMARD and were treated with tofacitinib or adalimumab.
Reproductive Experiences of Women With Inflammatory Arthritis
Investigators issued a comprehensive reproductive health survey to examine how inflammatory arthritis affects family planning, contraception, menstruation, and infertility.
Psoriasis Increases Risk for Immune-Mediated Inflammatory Diseases 5-Fold
Because of the lack of previous chronological evaluation, investigators examined the chronology of IMIDs in relation to psoriasis.
Target Serum Urate and Remission Difficult to Achieve in Severe Gout
The main obstacles for target serum urate and gout remission included poor medication adherence, persistent tophi, and loss to follow-up.
Research Confirms Importance of Individualized Treatment Choices in RA
Researchers collected evidence that showed patients with rheumatoid arthritis are generally risk-averse and require individualized treatment plans based upon guidelines that outline risks vs benefits.
Influence of Medical Malpractice on Shared Decision-Making Simulations
Researchers recently performed a simulation study to determine how 3 levels of shared decision making can increase the chances of patients suing for adverse outcomes.
Malondialdehyde-Acetaldehyde Antibodies in RA-Interstitial Lung Disease
Researchers conducted both serologic and tissue expression tests which revealed that for rheumatoid arthritis-associated interstitial lung disease immune responses from anti-malondialdehyde acetaldehyde adducts modified proteins may serve as biomarkers.
Family Planning, Fertility, and Rheumatoid Arthritis
Researchers found data that support many reasons for infertility in both men and women with rheumatoid arthritis. For the best chance for a successful pregnancy outcome, it is suggested that being on well controlled safe, anti-rheumatic drugs for at least 3 to 6 months prior to pregnancy provides the best chance for women patients with rheumatoid arthritis.
Next post in Rheumatoid Arthritis Advisor
